The company announced successful oxy-M results in October 2013, and a lot of patches were used in those trials. NOT EVEN A WHISPER ABOUT OCY-M PATCH PROBLEMS in October 2013, and a lot of shareholders bought into the company on the back of that announcement. Look at the volumes traded if you want to see for yourself. The share price rose to 16c. It is now about one-fifth of that.
I ask the forum whether the company knew about, or ought to have known about, problems with the patches back in October 2013. For example, was there any skin irritation back in October 2013? Has anyone on this forum been able to explain this silence about patch issues satisfactorily? Has the company? These are the types of issues that must be addressed if the company is to rebuild trust and credibility in the market.
Instead, I see posters criticising other posters, far too often. Those of you with excellent research skills and experience in biotechnology can add more value if you direct your concerns at the company for answers, and show a little more respect and tolerance for your fellow posters and different points of view.
All in my opinion, do your own research.
The company announced successful oxy-M results in October 2013,...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $11.50K | 4.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 101422109 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 20872825 | 7 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |